Switch theme
Sign up to access all valuation multiples
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
1997
1.2K+
LTM Revenue $333M
LTM EBITDA $76.7M
$160M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Quipt Home Medical has a last 12-month revenue (LTM) of $333M and a last 12-month EBITDA of $76.7M.
In the most recent fiscal year, Quipt Home Medical achieved revenue of $181M and an EBITDA of $37.5M.
Quipt Home Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Quipt Home Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $333M | XXX | $181M | XXX | XXX | XXX |
| Gross Profit | $241M | XXX | $130M | XXX | XXX | XXX |
| Gross Margin | 72% | XXX | 72% | XXX | XXX | XXX |
| EBITDA | $76.7M | XXX | $37.5M | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 21% | XXX | XXX | XXX |
| EBIT | -$2.2M | XXX | $2.6M | XXX | XXX | XXX |
| EBIT Margin | -1% | XXX | 1% | XXX | XXX | XXX |
| Net Profit | -$12.4M | XXX | -$5.0M | XXX | XXX | XXX |
| Net Margin | -4% | XXX | -3% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $47.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 2, 2025, Quipt Home Medical's stock price is CAD 2 (or $2).
Quipt Home Medical has current market cap of CAD 106M (or $77.9M), and EV of CAD 217M (or $160M).
See Quipt Home Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $160M | $77.9M | XXX | XXX | XXX | XXX | $-0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 2, 2025, Quipt Home Medical has market cap of $77.9M and EV of $160M.
Quipt Home Medical's trades at 0.8x EV/Revenue multiple, and 3.8x EV/EBITDA.
Equity research analysts estimate Quipt Home Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Quipt Home Medical has a P/E ratio of -8.6x.
See valuation multiples for Quipt Home Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $77.9M | XXX | $77.9M | XXX | XXX | XXX |
| EV (current) | $160M | XXX | $160M | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 2.8x | XXX | 3.8x | XXX | XXX | XXX |
| EV/EBIT | -98.5x | XXX | 121.7x | XXX | XXX | XXX |
| EV/Gross Profit | 0.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -8.6x | XXX | -12.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 6.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialQuipt Home Medical's last 12 month revenue growth is -3%
Quipt Home Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Quipt Home Medical's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Quipt Home Medical's rule of X is 16% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Quipt Home Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -3% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | -3% | XXX | 28% | XXX | XXX | XXX |
| Rule of 40 | 17% | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 71% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Quipt Home Medical acquired XXX companies to date.
Last acquisition by Quipt Home Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Quipt Home Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Quipt Home Medical founded? | Quipt Home Medical was founded in 1997. |
| Where is Quipt Home Medical headquartered? | Quipt Home Medical is headquartered in Canada. |
| How many employees does Quipt Home Medical have? | As of today, Quipt Home Medical has 1.2K+ employees. |
| Who is the CEO of Quipt Home Medical? | Quipt Home Medical's CEO is Mr. Gregory John Crawford. |
| Is Quipt Home Medical publicy listed? | Yes, Quipt Home Medical is a public company listed on TSE. |
| What is the stock symbol of Quipt Home Medical? | Quipt Home Medical trades under QIPT ticker. |
| When did Quipt Home Medical go public? | Quipt Home Medical went public in 1997. |
| Who are competitors of Quipt Home Medical? | Similar companies to Quipt Home Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Quipt Home Medical? | Quipt Home Medical's current market cap is $77.9M |
| What is the current revenue of Quipt Home Medical? | Quipt Home Medical's last 12 months revenue is $333M. |
| What is the current revenue growth of Quipt Home Medical? | Quipt Home Medical revenue growth (NTM/LTM) is -3%. |
| What is the current EV/Revenue multiple of Quipt Home Medical? | Current revenue multiple of Quipt Home Medical is 0.7x. |
| Is Quipt Home Medical profitable? | Yes, Quipt Home Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Quipt Home Medical? | Quipt Home Medical's last 12 months EBITDA is $76.7M. |
| What is Quipt Home Medical's EBITDA margin? | Quipt Home Medical's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Quipt Home Medical? | Current EBITDA multiple of Quipt Home Medical is 2.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
